ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 841

Prevalence of Systemic Sclerosis in Primary Biliary Cirrhosis Using the New ACR/EULAR Classification Criteria

Boyang Zheng1, Catherine Vincent2, Marvin J. Fritzler3, Jean-Luc Senécal4, Martial Koenig5 and France Joyal5, 1Division of Internal Medicine, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada, 2Division of Hepatology, Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada, 3Medicine, University of Calgary, Calgary, AB, Canada, 4Department of Medicine, Division of Rheumatology, Centre Hospitalier de l’Université de Montréal, Montreal, QC, Canada, 5Department of Medicine, Division of Internal Medicine, Centre Hospitalier de l’Université de Montréal, Montreal, QC, Canada

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: liver disease, scleroderma and systemic sclerosis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Systemic sclerosis (SSc) is a well established disease associated with primary biliary cirrhosis (PBC), however original 1980 American College of Rheumatology (ACR) criteria have poor sensitivity, especially for detection of earlier SSc in previous studies. The objective is to evaluate the prevalence of SSc in PBC patients using more sensitive 2001 LeRoy criteria and the recent 2013 ACR/European League Against Rheumatism (EULAR) classification criteria, and secondarily the frequency of individual clinical features.

Methods:

100 PBC patients without previously diagnosed SSc were recruited over 18 months from a tertiary care gastroenterology clinic. All patients underwent a clinical, biological, and capillaroscopic evaluation. Fulfillment of the three different criteria sets were analyzed.

Results:

1% of the PBC patients met the ACR 1980 criteria. 22% met the 2001 LeRoy’s criteria for early SSc and 16% the 2013 ACR/EULAR criteria. Raynaud phenomenon, SSc related antibodies and SSc nailfold capillaroscopy changes were the most prevalent findings with the highest sensitivities to help guide future screening.

Conclusion:

Our data show a high prevalence of SSc and possible underestimation of previous studies using the original ACR 1980 criteria. SSc based on newly described criteria may lead to improved detection and increased benefits of earlier treatment in ameliorating SSc related morbidity and mortality.


Disclosure: B. Zheng, None; C. Vincent, None; M. J. Fritzler, None; J. L. Senécal, None; M. Koenig, None; F. Joyal, None.

To cite this abstract in AMA style:

Zheng B, Vincent C, Fritzler MJ, Senécal JL, Koenig M, Joyal F. Prevalence of Systemic Sclerosis in Primary Biliary Cirrhosis Using the New ACR/EULAR Classification Criteria [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/prevalence-of-systemic-sclerosis-in-primary-biliary-cirrhosis-using-the-new-acreular-classification-criteria/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-systemic-sclerosis-in-primary-biliary-cirrhosis-using-the-new-acreular-classification-criteria/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology